glucuronidase

(redirected from beta-glucuronidase)
Also found in: Dictionary, Medical, Wikipedia.

glucuronidase

[‚glü·kyə′rän·ə‚dās]
(biochemistry)
An enzyme that catalyzes hydrolysis of glucuronides. Also known as glycuronidase.
References in periodicals archive ?
Enzyme potentiated hyposensitization II: Effect of glucose, glucosamine, N-acetylaminosugars and gelatin on the ability of beta-glucuronidase to block the anamnestic response to antigen in mice.
Buprenorphine Hydrolysis using a Novel Recombinant Beta-Glucuronidase for Urine Drug Testing.
Assay for beta-glucuronidase in species of the genus Escherichia and its applications for drinking-water analysis.
Preer and Phillip (2011) highlight that some conjugated bilirubin can be turned back into unconjugated bilirubin by an enzyme called beta-glucuronidase in the intestine and this unconjugated bilirubin is reabsorbed and returned to the liver via a process called 'enterohepatic circulation'.
30), (31) Reishi mushrooms limit the activity of beta-glucuronidase, an enzyme that is elevated in many liver conditions, including inflammation, cirrhosis, and jaundice.
Beta-glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-[Florin]] quinoline in rats.
Chromogenic substrate in the medium detects the beta-glucuronidase enzyme that is highly specific to E.
1987, "GUS fusions: beta-glucuronidase as a sensitive and versatile gene fusion rnarker in higher plants," EMBO J.
Inter-individual variability in expression and activity of human beta-glucuronidase in liver and kidney: consequences for drug metabolism.
Beta-glucuronidase -- A normal enzyme occurring abnormally in CSF in leptomeningeal carcinomatosis.
This is a preliminary report on the use of a relatively new technique--enzyme-potentiated desensitization (EPD)--that utilizes a mixture of extremely dilute antigens mixed with the enzyme beta-glucuronidase.
Because children with the disease lack a functional form of an enzyme called beta-glucuronidase (GUSB), Sands and associates tried to prevent the disorder by using AAV as a viral vector to deliver the GUSB to the mice.